Related Experiment Videos

Targeting NOX, INOS and COX-2 in inflammatory cells: chemoprevention using food phytochemicals

Akira Murakami1, Hajime Ohigashi

  • 1Division of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University, Kyoto, Japan. cancer@kais.kyoto-u.ac.jp

Insights

Certain food phytochemicals, like 1'-acetoxychavicol acetate from Zingiberaceae, can inhibit key inflammatory enzymes (NOX, iNOS, COX-2), potentially preventing inflammation-associated cancers.

Area of Science:

  • Biochemistry
  • Immunology
  • Molecular Biology

Background:

  • Inflammatory leukocytes, such as macrophages, produce proinflammatory molecules in response to stimuli.
  • Chronic activation of enzymes like NADPH oxidase (NOX), inducible nitric oxide synthase (iNOS), and cyclooxygenase-2 (COX-2) is linked to inflammatory diseases, including cancer.
  • While synthetic agents are used for cancer prevention, natural compounds from herbs and spices also show potential in disrupting inflammatory pathways.

Purpose of the Study:

  • To review the molecular mechanisms underlying the activation of NOX, iNOS, and COX-2.
  • To highlight food phytochemicals that can regulate these key inflammatory molecules.
  • To discuss the cancer-preventive potential of these phytochemicals.

Main Methods:

  • Review of literature on molecular mechanisms of NOX, iNOS, and COX-2.
  • Identification and analysis of food phytochemicals targeting these enzymes.
  • Examination of studies on cancer prevention activities of phytochemicals in animal models.

Main Results:

  • 1 '-acetoxychavicol acetate, found in Zingiberaceae, reduces NOX-derived superoxide generation and suppresses iNOS and COX-2 synthesis.
  • This phytochemical attenuates nitric oxide and prostaglandin E(2) production.
  • 1 '-acetoxychavicol acetate demonstrates significant cancer prevention activities in rodent models of inflammation-associated carcinogenesis.

Conclusions:

  • Food phytochemicals offer a promising avenue for regulating key inflammatory molecules involved in carcinogenesis.
  • Targeting NOX, iNOS, and COX-2 with natural compounds like 1 '-acetoxychavicol acetate may be effective in cancer prevention strategies.
  • Further research into phytochemicals can lead to novel approaches for managing inflammatory diseases and preventing cancer.

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...